Drug intelligence / Profile preview

Cihu Xiaotong Decoction

Development stage: Preclinical
Lead developer: Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine
Administration: Oral

Overview

Cihu Xiaotong Decoction is a self-formulated traditional Chinese medicine (TCM) decoction currently under investigation for its clinical efficacy in treating acute gouty arthritis. Specifically, it is being studied for its effects on gouty arthritis presenting with a 'dampness heat toxin stasis syndrome' according to TCM diagnostic principles. The Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine is involved in its clinical evaluation.

Beyond the preview

Go deeper on Cihu Xiaotong Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cihu Xiaotong Decoction.

Explore the full profile